It has been shown that VEGF inhibition transiently normalizes tumor vessels, whereas angiopoietin inhibition leads to a stable normalization of tumor vasculature, enhancing the anti-tumor immune response in both cases [51,52]. The gene discussed is VEGFA; the disease is neoplasm.